Evaluation of the efficacy of an imidacloprid 10%/moxidectin 2.5% spot-on against Sarcoptes scabieivar canison dogs
- PMID: 12928880
- DOI: 10.1007/s00436-003-0916-4
Evaluation of the efficacy of an imidacloprid 10%/moxidectin 2.5% spot-on against Sarcoptes scabieivar canison dogs
Similar articles
-
Larvicidal and persistent efficacy of an imidacloprid and moxidectin topical formulation against endoparasites in cats and dogs.Parasitol Res. 2003 Jul;90 Suppl 3:S114-5. doi: 10.1007/s00436-003-0907-5. Epub 2003 Aug 19. Parasitol Res. 2003. PMID: 12928872 Clinical Trial. No abstract available.
-
Efficacy and safety of imidacloprid 10% plus moxidectin 2.5% spot-on in the treatment of sarcoptic mange and otoacariosis in dogs: results af a European field study.Parasitol Res. 2005 Oct;97 Suppl 1:S81-S88. doi: 10.1007/s00436-005-1449-9. Parasitol Res. 2005. PMID: 16228280 Clinical Trial.
-
The efficacy of an imidacloprid/moxidectin combination against naturally acquired Sarcoptes scabiei infestations on dogs.Aust Vet J. 2006 Jan-Feb;84(1-2):17-21. doi: 10.1111/j.1751-0813.2006.tb13117.x. Aust Vet J. 2006. PMID: 16498829 Clinical Trial.
-
Current trends in the treatment of Sarcoptes, Cheyletiella and Otodectes mite infestations in dogs and cats.Vet Dermatol. 2004 Apr;15(2):108-14. doi: 10.1111/j.1365-3164.2004.00362.x. Vet Dermatol. 2004. PMID: 15030559 Review.
-
An update on the therapy of canine demodicosis.Compend Contin Educ Vet. 2012 Apr;34(4):E1-4. Compend Contin Educ Vet. 2012. PMID: 22488596 Review.
Cited by
-
Efficacy of afoxolaner plus milbemycin oxime and afoxolaner alone as treatment for sarcoptic mange in naturally infested dogs.Can J Vet Res. 2020 Jul;84(3):212-216. Can J Vet Res. 2020. PMID: 32801456 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical